These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24178031)

  • 1. Vpr expression abolishes the capacity of HIV-1 infected cells to repair uracilated DNA.
    Eldin P; Chazal N; Fenard D; Bernard E; Guichou JF; Briant L
    Nucleic Acids Res; 2014 Feb; 42(3):1698-710. PubMed ID: 24178031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Vpr loads uracil DNA glycosylase-2 onto DCAF1, a substrate recognition subunit of a cullin 4A-ring E3 ubiquitin ligase for proteasome-dependent degradation.
    Ahn J; Vu T; Novince Z; Guerrero-Santoro J; Rapic-Otrin V; Gronenborn AM
    J Biol Chem; 2010 Nov; 285(48):37333-41. PubMed ID: 20870715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HIV1 protein Vpr acts to enhance constitutive DCAF1-dependent UNG2 turnover.
    Wen X; Casey Klockow L; Nekorchuk M; Sharifi HJ; de Noronha CM
    PLoS One; 2012; 7(1):e30939. PubMed ID: 22292079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uracil DNA glycosylase interacts with the p32 subunit of the replication protein A complex to modulate HIV-1 reverse transcription for optimal virus dissemination.
    Herate C; Vigne C; Guenzel CA; Lambele M; Rouyez MC; Benichou S
    Retrovirology; 2016 Apr; 13():26. PubMed ID: 27068393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of HIV-1 Vpr manipulation of the DNA repair enzyme UNG2 on B lymphocyte class switch recombination.
    Eldin P; Péron S; Galashevskaya A; Denis-Lagache N; Cogné M; Slupphaug G; Briant L
    J Transl Med; 2020 Aug; 18(1):310. PubMed ID: 32778120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The DDB1-DCAF1-Vpr-UNG2 crystal structure reveals how HIV-1 Vpr steers human UNG2 toward destruction.
    Wu Y; Zhou X; Barnes CO; DeLucia M; Cohen AE; Gronenborn AM; Ahn J; Calero G
    Nat Struct Mol Biol; 2016 Oct; 23(10):933-940. PubMed ID: 27571178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 and HIV-2 exhibit divergent interactions with HLTF and UNG2 DNA repair proteins.
    Hrecka K; Hao C; Shun MC; Kaur S; Swanson SK; Florens L; Washburn MP; Skowronski J
    Proc Natl Acad Sci U S A; 2016 Jul; 113(27):E3921-30. PubMed ID: 27335459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recruitment of the nuclear form of uracil DNA glycosylase into virus particles participates in the full infectivity of HIV-1.
    Guenzel CA; Hérate C; Le Rouzic E; Maidou-Peindara P; Sadler HA; Rouyez MC; Mansky LM; Benichou S
    J Virol; 2012 Mar; 86(5):2533-44. PubMed ID: 22171270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1.
    Schröfelbauer B; Hakata Y; Landau NR
    Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4130-5. PubMed ID: 17360488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cullin4A and cullin4B are interchangeable for HIV Vpr and Vpx action through the CRL4 ubiquitin ligase complex.
    Sharifi HJ; Furuya AK; Jellinger RM; Nekorchuk MD; de Noronha CM
    J Virol; 2014 Jun; 88(12):6944-58. PubMed ID: 24719410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uracil DNA Glycosylase 2 negatively regulates HIV-1 LTR transcription.
    Fenard D; Houzet L; Bernard E; Tupin A; Brun S; Mougel M; Devaux C; Chazal N; Briant L
    Nucleic Acids Res; 2009 Oct; 37(18):6008-18. PubMed ID: 19696076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus type 1 Vpr modulates cellular expression of UNG2 via a negative transcriptional effect.
    Langevin C; Maidou-Peindara P; Aas PA; Jacquot G; Otterlei M; Slupphaug G; Benichou S
    J Virol; 2009 Oct; 83(19):10256-63. PubMed ID: 19625402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases.
    Schröfelbauer B; Yu Q; Zeitlin SG; Landau NR
    J Virol; 2005 Sep; 79(17):10978-87. PubMed ID: 16103149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Uracil-DNA Glycosylase UNG2 a New Cellular Weapon Against HIV-1?
    Kara H; Chazal N; Bouaziz S
    Curr HIV Res; 2019; 17(3):148-160. PubMed ID: 31433761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Backbone resonance assignment of the human uracil DNA glycosylase-2.
    Kara H; Ponchon L; Bouaziz S
    Biomol NMR Assign; 2018 Apr; 12(1):37-42. PubMed ID: 28940147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vpr-mediated incorporation of UNG2 into HIV-1 particles is required to modulate the virus mutation rate and for replication in macrophages.
    Chen R; Le Rouzic E; Kearney JA; Mansky LM; Benichou S
    J Biol Chem; 2004 Jul; 279(27):28419-25. PubMed ID: 15096517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages.
    Lahouassa H; Blondot ML; Chauveau L; Chougui G; Morel M; Leduc M; Guillonneau F; Ramirez BC; Schwartz O; Margottin-Goguet F
    Proc Natl Acad Sci U S A; 2016 May; 113(19):5311-6. PubMed ID: 27114546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 Vpr Protein Enhances Proteasomal Degradation of MCM10 DNA Replication Factor through the Cul4-DDB1[VprBP] E3 Ubiquitin Ligase to Induce G2/M Cell Cycle Arrest.
    Romani B; Shaykh Baygloo N; Aghasadeghi MR; Allahbakhshi E
    J Biol Chem; 2015 Jul; 290(28):17380-9. PubMed ID: 26032416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 Vpr counteracts HLTF-mediated restriction of HIV-1 infection in T cells.
    Yan J; Shun MC; Zhang Y; Hao C; Skowronski J
    Proc Natl Acad Sci U S A; 2019 May; 116(19):9568-9577. PubMed ID: 31019079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repair of U/G and U/A in DNA by UNG2-associated repair complexes takes place predominantly by short-patch repair both in proliferating and growth-arrested cells.
    Akbari M; Otterlei M; Peña-Diaz J; Aas PA; Kavli B; Liabakk NB; Hagen L; Imai K; Durandy A; Slupphaug G; Krokan HE
    Nucleic Acids Res; 2004; 32(18):5486-98. PubMed ID: 15479784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.